IPO Market — India IPO tracker
Himalaya Nutravedics India logo

Himalaya Nutravedics India IPO

LISTEDSMEHNIL
SME IPO Dashboard →
Share
Save to watchlist

Listing Performance

▲ 11.32%

Issue Price

₹106

Listing Price

₹118

Listed On

29 Sep 2026

Price Band
₹100 – ₹106
Lot Size
1,200
Lot Value
₹1,27,200
Open Date
22 Sep
Close Date
24 Sep
Min Investment
₹1,27,200
Check Himalaya Nutravedics India price on NSE / BSE →

About Himalaya Nutravedics India

Himalaya Nutravedics manufactures and supplies a range of Ayurvedic and nutraceutical products across multiple dosage forms, including softgel capsules, hardgel capsules, tablets, liquid orals, medicated oils, and protein powders. The company operates through a single integrated manufacturing facility located in Hyderabad, Telangana. Its product portfolio covers therapeutic categories such as pain management, infertility, women’s wellness, gut health, neurological support, and general wellness. The business generates revenue primarily from the sale of Ayurvedic formulations, alongside nutraceutical offerings. The company operates mainly through a business-to-business model, supplying products to stockists, distributors, and third-party contract manufacturing clients across various states in India. It also undertakes custom contract manufacturing for corporate clients under their own brand names utilizing its manufacturing infrastructure. Furthermore, the company is expanding its market presence into direct-to-consumer sales channels through digital platforms, e-commerce marketplaces, and quick commerce delivery services.

Manufactures Ayurvedic and nutraceutical products for branded and contract manufacturing business.

CIN: U24110TG2022PLC163732Registered Office: Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal, Hyderabad – 500051, Telangana, IndiaFace Value: ₹10www.himalayanutravedics.com

Use of IPO Proceeds

Funding Working Capital RequirementsWorking capital₹13.75 Cr
Investment in Branding, Digital Marketing and Sales ExpansionCapital expenditure₹7.5 Cr
General Corporate PurposesGeneral corporate purposes—

Promoters

Chanda Asawa

Promoter · age 60

Over 07 years

She does not hold any professional educational qualification.

Divya Asawa

Promoter

Rama Raju Penmatsa

Promoter · age 65

Over 0.4 year

He does not hold any professional educational qualification.

Rohit Asawa

Promoter

Investment Analysis

Quick Analysis: 5 strengths · 5 risk factors· Exchange: BSE SME

Strengths (5)

  • •Integrated manufacturing facility capable of producing multiple dosage forms.
  • •Diverse Ayurvedic and nutraceutical product portfolio across key therapeutic areas.
  • •Established B2B distribution network with presence across 17 Indian states.
  • •Track record of strong revenue and net profit growth over recent fiscal years.
  • •In-house quality assurance and control capabilities across production processes.

Risk Factors (5)

  • •High revenue reliance on Ayurvedic products, accounting for over 90% of sales.
  • •Significant revenue concentration from top 10 customers representing over 80% of revenue.
  • •Operations from a single leased manufacturing facility located in Hyderabad, Telangana.
  • •Pending trademark opposition proceedings for corporate logos and mark applications.
  • •History of negative cash flows from operating activities due to working capital needs.

Demand snapshot

Subscription and grey market data as reported. Not a recommendation.

  • Subscribed 2.23x (QIB 1.00x, NII 2.87x, Retail 2.56x) at close

Investor Quota

QIB 50%
NII / HNI 15%
Retail 35%

Approx. shares reserved per category

QIB (50%)12,50,000 shares
NII / HNI (15%)3,75,000 shares
Retail (35%)8,75,000 shares

Estimated from total issue size; actual reserved lots are set in the RHP.

Application Lot Sizes

Retail caps at ₹2,00,000 (1 lots here). S-HNI is ₹2L–₹10L, B-HNI is above ₹10L.

CategoryLotsSharesAmount
Retail (min)11,200₹1,27,200
Retail (max)11,200₹1,27,200
S-HNI (min)22,400₹2,54,400
S-HNI (max)78,400₹8,90,400
B-HNI (min)89,600₹10,17,600

Subscription Status

Overall subscription2.23x(Day 3)
Updated 50 days ago
CategoryDay 1Day 2Day 3
QIB——1.00x
sNII (S-HNI)———
bNII (B-HNI)———
Retail0.16x0.66x2.56x
Total0.10x0.41x2.23x

Colour: red <1x · amber 1–10x · green ≥10x oversubscribed.

Allotment Statistics

Retail Individual Investors (RII)

Subscription

2.56x

Allotment Ratio

1 lot per 3 applicants

Allotment Probability

~39.1%

Non-Institutional Investors (NII / HNI)

Subscription

2.87x

Allotment Type

Proportionate allotment

Qualified Institutional Buyers (QIB)

Subscription

1.00x

Allotment Type

Discretionary allotment

Total Subscription

2.23x

Allotment probability is estimated based on subscription data and is not guaranteed. Actual allotment depends on the registrar's process.

Basis of Allotment

Category-wise subscription & allotment ratio

View →

IPO Timeline

Issue Opens

22 Sep 2026 · Tue

Issue Closes

24 Sep 2026 · Thu

UPI Deadline

24 Sep 2026 · Thu

Allotment

25 Sep 2026 · Fri

Refund

28 Sep 2026 · Mon

Share Credit

28 Sep 2026 · Mon

Listing

29 Sep 2026 · Tue

IPO Details

RegistrarKFin Technologies Limited
ExchangeBSE SME
ISIN—
Face Value₹10
Issue Size₹26.50 Cr
Fresh Issue—
OFS Size—
Lead ManagersNIRBHAY CAPITAL SERVICES PRIVATE LIMITED

3-Year Financial Summary

Revenue trend

↑ FY24→FY26

Fiscal YearRevenue (₹Cr)PAT (₹Cr)EPSP/EROE
FY2643.077.3918.475.7445.12%
FY25212.235.5819.0033.08%
FY2414.430.431.0799.5331.77%

Detailed Line Items (₹ Cr)

Line ItemFY24FY25FY26
Total Income14.432143.12
EBITDA0.942.998.1
Net Worth1.346.7516.38

From the company's offer document (DRHP/RHP); restated figures where available.

Valuation at Issue Price

Issue P/E

5.7x

Price ÷ EPS

EPS (FY26)

₹18

Earnings per share

RoNW

45.12%

Return on net worth

ROCE

—

Not in abridged DRHP

EBITDA margin

18.8%

EBITDA ÷ revenue

Price/NAV

4.08x

Price ÷ NAV (as reported)

Check the valuation yourself

Company Fundamentals

14 sections extracted from this filing

Capital Structure

Authorised Capital₹10.00 Cr
Issued Capital₹6.31 Cr
Paid-up Capital₹6.31 Cr
Equity Shares (Pre-Issue)40,00,000
Equity Shares (Post-Issue)63,06,720

Source: Himalaya Nutravedics India offer document (DRHP/RHP).

Shareholding Pattern

Pre-Issue

  • Rohit Asawa(Promoter)+4.95%
  • Divya Asawa(Promoter)+25.55%
  • Chanda Asawa(Promoter)+45.38%
  • Sneha Penmatsa(Promoter)+8.00%
  • Krishna Kiran Kakarlapudi(Promoter)+16.00%
  • Umesh Chand Asawa(Promoter)+0.13%
Total+100.01%

Post-Issue

  • Rohit Asawa(Promoter)+4.71%
  • Divya Asawa(Promoter)+24.31%
  • Chanda Asawa(Promoter)+43.17%
  • Rama Raju Penmatsa(Promoter)+15.22%
  • Swati Penmatsa(Promoter)+7.61%
  • Umesh Chand Asawa(Promoter)+0.08%
Total+95.10%

Source: Himalaya Nutravedics India offer document (DRHP/RHP).

Reservations & OFS

Investor Reservation

  • Anchor60.00%
  • QIB50.00%
  • NII / HNI15.00%
  • Retail35.00%

OFS Selling Shareholders

No offer-for-sale component (or sellers not disclosed).

Source: Himalaya Nutravedics India offer document (DRHP/RHP).

Board & Management

Board of Directors (4)
  • Rohit Asawa₹0.24 Cr p.a.

    Chairman and Managing Director

    Founder with background in financial management, cost control and operational accuracy

  • Divya Asawa₹0.00 Cr p.a.

    Non-Executive Director

  • Abhisheak Dhoot₹0.00 Cr p.a.

    Independent Director

    Bachelor of Commerce, Associate Member of the Institute of Chartered Accountants of India

    Over 8 years of experience in taxation, auditing and financial advisory

  • Ramya Inala₹0.00 Cr p.a.

    Independent Director

    Bachelor of Arts and Bachelor of Laws (B.A., LL.B) from PG College of Law, Osmania University; Company Secretary

    Over 7 years of experience in legal, corporate secretarial and advisory matters

Key Managerial Personnel (2)
  • Krishna Kanth Sarda

    Chief Financial Officer

    Bachelor's degree in Commerce from Osmania University, Hyderabad; Diploma in Management from Aurora's Business School, Hyderabad

    Over 5 years in accounting and finance industry

  • Pooja Biyani

    Company Secretary and Compliance Officer

    Provisional degree in Bachelor's of Commerce from Osmania University, Hyderabad; Associate member of the Institute of Company Secretaries of India

    Over 3 years in secretarial industry

Source: Himalaya Nutravedics India offer document (DRHP/RHP).

Industry & Market

Market Size (TAM)
₹3040.00 Cr
Growth (CAGR)
+13.60%

Per Infomerics Analytics & Research, a report commissioned by the company (not independent).

Peer Comparison

CompanyP/EEPSRoNW %NAV
Himalaya Nutravedics India Limited—12.0545.1226.7
Jeena Sikho Lifecare Limited28.7517.8427.6737.6
Sandu Pharmaceuticals Limited20.621.832.5345.21

Material Litigation

TypeAgainstMattersAmount (₹Cr)
TaxCompany10.273

Direct tax case regarding disallowed Section 80-IAC deduction; appeal pending with appellate authority

Registrar (RTA)

SEBI-registered Registrar & Transfer Agent — handles allotment and refunds.

Registrar:KFin Technologies Limited→

Lead Managers (BRLMs)

Click any merchant banker for their full IPO track record (positive listing rate, average gain, IPOs managed).

Documents

Frequently Asked Questions

When is the Himalaya Nutravedics India IPO opening?

The Himalaya Nutravedics India IPO opens on 22 Sep 2026 and closes on 24 Sep 2026. Check this page for the latest updates as we refresh every 30 minutes.

What is the price band of the Himalaya Nutravedics India IPO?

The price band for the Himalaya Nutravedics India IPO is ₹100 to ₹106. The final price is announced after the book-building process and is confirmed before listing.

What is the lot size and minimum investment for the Himalaya Nutravedics India IPO?

The minimum lot size is 1200 shares with a minimum investment of ₹1,27,200. Retail investors can apply for up to the retail limit defined by SEBI.

What is the GMP of Himalaya Nutravedics India IPO today?

The latest Grey Market Premium for Himalaya Nutravedics India is ₹0 (+0.00%). GMP is unofficial data and is not a guarantee of listing price.

When will the Himalaya Nutravedics India IPO list on NSE and BSE?

The Himalaya Nutravedics India IPO is expected to list on 29 Sep 2026 on BSE SME. Actual listing day trading begins at the start of the normal market session.

How can I check the Himalaya Nutravedics India IPO allotment status?

The registrar for this IPO is KFin Technologies Limited. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.

Is the Himalaya Nutravedics India IPO a mainboard or SME issue?

Himalaya Nutravedics India is a SME IPO that will list on the NSE Emerge or BSE SME platform. SME IPOs require a minimum application value of one lakh rupees.

How do I apply for the Himalaya Nutravedics India IPO?

You can apply for the Himalaya Nutravedics India IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA while the issue is open for bidding.

What is the GMP-implied price of Himalaya Nutravedics India IPO?

The GMP-implied price (unofficial, not a forecast) is ₹106: the upper price band of ₹106 plus the latest grey market premium of ₹0, as of 29 Sep 2026, 11:33 PM IST. GMP is unofficial grey market data, and the actual listing price can differ from it.

What is the allotment ratio for Himalaya Nutravedics India IPO?

Based on the retail subscription of 2.56x, the estimated allotment ratio is 1 lot per 3 applicants (approximately 39.1% chance of allotment). This is an estimate and actual allotment may vary.

Recently Listed IPOs

CompanyListedListing Gain
Antala Industries11 Nov 2026-20.00%
Vedant Poly Fabs09 Nov 2026+0.00%
Maxwell Engineering Solutions06 Nov 2026+90.00%

Related IPOs

Related Articles

Financial Disclaimer: The information on this page is for educational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Grey Market Premium (GMP) figures are unofficial and not endorsed by SEBI, NSE, or BSE. Past performance is not indicative of future returns. Please read the RHP and consult a SEBI-registered advisor before investing.